A phase I dose escalation study of BGB-290 in Chinese subjects with advanced ovarian, fallopian, and primary peritoneal, or advanced triple-negative breast cancer | |
Xu, Binghe; Yin, Yongmei; Song, Yan; Li, Wei; Huang, Xiang; Brachmann, Rainer; Tang, Tristin; Yang, Haiyuan; Ge, Ruimin; Mu, Song | |
2018 | |
卷号 | 78期号:13 |
ISSN号 | 0008-5472 |
DOI | 10.1158/1538-7445.AM2018-CT050 |
URL标识 | 查看原文 |
收录类别 | SCIE |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6347109 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Xu, Binghe,Yin, Yongmei,Song, Yan,et al. A phase I dose escalation study of BGB-290 in Chinese subjects with advanced ovarian, fallopian, and primary peritoneal, or advanced triple-negative breast cancer[J],2018,78(13). |
APA | Xu, Binghe.,Yin, Yongmei.,Song, Yan.,Li, Wei.,Huang, Xiang.,...&Dong, Mei.(2018).A phase I dose escalation study of BGB-290 in Chinese subjects with advanced ovarian, fallopian, and primary peritoneal, or advanced triple-negative breast cancer.,78(13). |
MLA | Xu, Binghe,et al."A phase I dose escalation study of BGB-290 in Chinese subjects with advanced ovarian, fallopian, and primary peritoneal, or advanced triple-negative breast cancer".78.13(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论